TWO · Healthcare

InnoPharmax Inc. (4172)

Drug Manufacturers - Specialty & Generic

InnoPharmax Inc. (4172) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 4172

P/E ratio

18.00

InnoPharmax Inc. (4172) — FAQ

What is 4172's P/E ratio?

The price-to-earnings (P/E) ratio for InnoPharmax Inc. (4172) is 18.00 (data as of 2026-03-23).

Does InnoPharmax Inc. pay a dividend?

Dividend yield is not available in the current snapshot for InnoPharmax Inc. (4172). Check the MyAverix Finance app for the latest dividend data.

What sector is InnoPharmax Inc. in?

InnoPharmax Inc. (4172) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 4172 listed on?

4172 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)